Chinese english Germany Japanese Korea

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine Struktur
511514-16-2
CAS-Nr.
511514-16-2
Englisch Name:
N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine
Synonyma:
Guanidine, N-[4-[(2-benzothiazolylthio)methyl]-1,6-dihydro-6-oxo-2-pyrimidinyl]-N'-(4-phenoxyphenyl)-;N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine
CBNumber:
CB01980404
Summenformel:
C25H20N6O2S2
Molgewicht:
500.6
MOL-Datei:
511514-16-2.mol
Request For Quotation

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine Eigenschaften

Siedepunkt:
652.1±65.0 °C(Predicted)
Dichte
1.45±0.1 g/cm3(Predicted)
pka
7.76±0.50(Predicted)

Sicherheit

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine Chemische Eigenschaften,Einsatz,Produktion Methoden

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
Specs --
 info@specs.net The Netherlands 6835 70
  • N-{6-[(1,3-benzothiazol-2-ylsulfanyl)methyl]-4-oxo-1,4-dihydropyrimidin-2-yl}-N''-(4-phenoxyphenyl)guanidine
  • Guanidine, N-[4-[(2-benzothiazolylthio)methyl]-1,6-dihydro-6-oxo-2-pyrimidinyl]-N'-(4-phenoxyphenyl)-
  • 511514-16-2
  • C25H20N6O2S2
Copyright 2019 © ChemicalBook. All rights reserved